# The EVICEL® Gastrointestinal Study

> **NCT01589822** · PHASE2 · COMPLETED · sponsor: **Ethicon, Inc.** · enrollment: 214 (actual)

## Conditions studied

- Gastrointestinal Diseases

## Interventions

- **BIOLOGICAL:** EVICEL Fibrin Sealant

## Key facts

- **NCT ID:** NCT01589822
- **Lead sponsor:** Ethicon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2014-01
- **Final completion:** 2014-09
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2015-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01589822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01589822, "The EVICEL® Gastrointestinal Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01589822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*